Search Results

Digital Supplement | March 2020 Supplement

OTC Skincare Today

Can dermatologists afford to ignore patients’ growing use of OTC products?

Bryan Bechtel

Feature | July 2019

What Does Dermatology Need Right Now?

Experts weigh in on the pressing needs of the specialty today.

Sandra Marchese Johnson, MD; Eric Bernstein, MD, MSE, FAD; Jeffrey T. S. Hsu, MD, FAAD; Doris Day, MD, FAAD; Stefan C. Weiss, MD, MBA, FAAD; Anisha Patel, MD, FAAD; and Mark A. Bechtel, MD, FAAD

@practical_derm | December 2015

Your Destination for the Latest Developments in #Dermatology in Print and Online

November 2015

Enhancing Treatment Adherence

Devising a strategy to engage patients in their treatment regimen for better results.

Mark Bechtel, MD, Gary Goldenberg, MD, and Andrew C. Krakowski, MD

@practical_derm | June 2015

@PRACTICAL_DERM

Physician Spotlight | January 2015

Editorial Board Forum: Dermatology in 2015

Physician Focus | December 2014

2014 Editorial Board Forum

February 2013

Advances in Clinical Trial Development of Biologics in the Treatment of Psoriasis

Developers are eyeing new therapeutic targets for biologic treatments for psoriasis.

Mark A. Bechtel, MD, Amy L. Levinson, BA, BSN, RN, Anne M. Bechtel, BSN, RN

Resident's Reports | October 2012

Prednisone-induced DRESS Syndrome

This unusual reaction was resolved with a switch to a Group C steroid.

Sarah Grim Hostetler, MD, Mark Bechtel, MD, and Matt Zirwas, MD

December 2011

Rosacea: Choosing Among the Topical and Systemic Therapeutic Options

As the field of therapies available for rosacea has expanded, clinicians must weigh the topical and oral treatment options on a case-by-case basis

Mark Bechtel, MD and Ann Bechtel, BSN

June 2010

The Biologic Field: Where Has It Been and Where Is It Heading?

Seven years since the first biologic received approval for psoriasis, the expanding field remains promising. But questions remain.

Mark Bechtel, MD and Ann Bechtel, BSN

January 2010

Complications of Biologic Therapy for Psoriasis: Part II

Therapeutic success requires clinicians to understand emerging and established safety concerns.

Kyle Bauer, BA and Mark Bechtel, MD

November/December 2009

A Review of Complications of Biologic Therapy for Psoriasis

Therapeutic success requires clinicians to understand emerging and established safety concerns.

Kyle Bauer, BA and Mark Bechtel, MD